Dog-Assisted Therapy in Dentistry

July 30, 2019 updated by: University of Tromso

Dog-Assisted Therapy in Dental Care Settings

Dog-assisted therapy (DAT) is used in several contexts within various areas of health care. One documented effect is that the proximity of a dog may lower anxiety in perceived stressful situations. Many individuals are afraid to visit the dentist, and someone to the extent that they need medication or anesthesia in order to complete their dental treatment. Based on the literature and own empirical observations, the investigators believe that dog-assisted therapy in connection with dental care may have a positive effect on children with dental anxiety or children that avoid dental care. It is desirable to restrict the use of drugs for these patients because of associated risk and side effects.

The purpose of this pilot study is to evaluate whether using a specially trained therapy dog can have a positive effect on children who are afraid in a dental care setting. Eligible participants (n=16) will meet twice at the dental clinic; one treatment session with a therapy dog in the dental clinic and one without. The therapy dog will be accompanied by a certified dog handler. The investigators will measure physiological variations before, during and after the treatment session. The guardian will complete validated questionnaires portraying the participant's experience of previous dental care. The participant and their guardian will also complete validated questionnaires describing their reactions from the two treatment sessions. A descriptive log for each session will be completed by the investigators.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tromsø, Norway, N-9037
        • Department of Clinical Dentistry, UiT The Arctic University of Norway

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 12 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Children who are afraid of visiting the dental office / children who avoid dental treatment,
  • Children who accept the presence of a dog,
  • Parents or guardians who accept the presence of a dog

Exclusion Criteria:

  • Children or parent/guardian that are afraid of dogs,
  • Children or parent/guardian with known dog allergy,
  • Children who are immunocompromised,
  • Children who cannot understand or complete the patient-questionnaire

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Therapydog
A certified therapydog (together with a certified dog-handler) will be present in the dental clinic while the child will undergo a clinical dental examination by licenced pediatric dentist.
Presence of a therapydog during a clinical examination in a dental clinic
NO_INTERVENTION: No therapydog
No therapydog will be present in the dental clinic while the child will undergo a clinical dental examination by licenced pediatric dentist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Examination achieved; Yes or No
Time Frame: up to 8 weeks
Whether the child complied or not, so that a clinical oral examination could be accomplished within 30 minutes
up to 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Child satisfaction
Time Frame: up to 8 weeks
The child will describe his/her feelings by marking one of 6 different emoticon-style facial expressions where number 1 illustrate the most happy face and number 6 illustrates not happy at all.
up to 8 weeks
Measurement of anxiety through the CFSS-DS scale (Dental subscale of Children's Fear Survey Schedule)
Time Frame: up to 8 weeks
The parent/guardian will describe the child's dental fear on a five point scale where 1 is no fear and 5 is the worst fear.
up to 8 weeks
Salivary cortisol level
Time Frame: up to 8 weeks
Measurement of cortisol from participant's saliva sample to assess if dog-assisted therapy (DAT) minimizes stress and anxiety
up to 8 weeks
Heart rate variability
Time Frame: up to 8 weeks
Heart rate will be measured to assess if dog-assisted therapy (DAT) minimizes stress and anxiety. (Biopac Systems software)
up to 8 weeks
Skin conductance (Electrodermal activity)
Time Frame: up to 8 weeks
Skin conductance will be measured to assess if dog-assisted therapy (DAT) minimizes stress and anxiety. (Biopac Systems software)
up to 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anne M Gussgard, DDS,MSc,PhD, Department of Clinical Dentistry, UiT The Arctic University of Norway

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 31, 2017

Primary Completion (ACTUAL)

June 5, 2019

Study Completion (ACTUAL)

June 5, 2019

Study Registration Dates

First Submitted

October 11, 2017

First Submitted That Met QC Criteria

October 24, 2017

First Posted (ACTUAL)

October 27, 2017

Study Record Updates

Last Update Posted (ACTUAL)

July 31, 2019

Last Update Submitted That Met QC Criteria

July 30, 2019

Last Verified

October 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Anxiety

Subscribe